ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
Alphabet Inc. closed a $5 billion investment in Isomorphic Labs, led by Greenoaks and Sequoia Capital. The funding supports the company's AI-driven drug discovery platform, IsoDDE, which aims to accelerate therapeutic programs toward clinical trials by improving protein modeling precision.
Tap to vote and see what everyone thinks.
Summary by ByteBrief